Why is Cell Point falling/rising?

As of 10-Sep, Cell Point (India) Ltd's stock is currently priced at 18.75, reflecting a decrease of 0.4, or 2.09%. The stock has underperformed its sector today by 1.7%, and the delivery volume has seen a significant decline of 16.67% compared to the 5-day average, indicating falling investor participation. Despite this, the stock has shown positive returns over the past week and month, with increases of 3.88% and 12.61%, respectively. However, it has a year-to-date decline of 29.91% and a one-year drop of 42.75%, suggesting long-term challenges. There are no positive or negative dashboard factors available to further explain the stock's recent movement.
Broader Market Context: In comparison to the benchmark Sensex, which has gained 1.04% over the past week and 2.50% over the past month, Cell Point's recent performance has been stronger in the short term but remains significantly lower year-to-date and over the past year. The broader market has shown resilience, with the Sensex up 5.62% year-to-date, contrasting with Cell Point's substantial decline. This disparity highlights the challenges faced by Cell Point in attracting investor interest despite some short-term gains.